Legislative Update: Food Imports, Pharmaceuticals, WTO
For more information on pursuing trade policy interests through the legislative process, please contact trade consultant Nicole Bivens Collinson.
Food Imports. Rep. Ted Yoho, R-Fla., sent a letter to President Trump April 28 asking him to “invoke a force majeure motion to stop the importation of all Mexican, Central American, and South American food products,” including fresh fruit, vegetable, dairy, and meat products, during the COVID-19 pandemic. Yoho asserted that the U.S. should not be importing such goods when there is already “a glut of products within our borders” and “farmers are having to plow up their harvest-ready crops because of a market collapse and factors outside their control.”
Pharmaceuticals. The Protecting Our Pharmaceutical Supply Chain from China Act (H.R. 6482, introduced April 10 by Rep. Gallagher, R-Wis.) would require the Department of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the U.S. and ban the use of federal funds for the purchase of drugs manufactured in China.
WTO. The Enforcing Accountability and Transparency in International Trade Act (H.R. 6627, introduced April 24 by Rep. Yoho, R-Fla.) would (1) require the Office of the U.S. Trade Representative to report on plans to facilitate the full implementation of World Trade Organization agreements and (2) prevent high-income nations (like China) from continuing to qualify under certain conditions from seeking developing nation status under trade agreements to received special and differential treatment.